Profil
Alex Mogle is currently a Director at Pharma Two B Ltd. and a Director & Vice President-Corporate Development at Mapi-Pharma Ltd. He was previously a Vice President-Strategy at Stem Cell Medicine Ltd. Mr. Mogle received an undergraduate degree and an MBA from The Hebrew University of Jerusalem.
Postes actifs de Alex Mogle
| Sociétés | Poste | Début |
|---|---|---|
| MAPI PHARMA LTD | Directeur/Membre du Conseil | 01/06/2012 |
Pharma Two B Ltd.
Pharma Two B Ltd. Pharmaceuticals: MajorHealth Technology Manufactures combination drugs for neurological disorders | Directeur/Membre du Conseil | - |
Anciens postes connus de Alex Mogle
| Sociétés | Poste | Fin |
|---|---|---|
Stem Cell Medicine Ltd.
Stem Cell Medicine Ltd. Pharmaceuticals: OtherHealth Technology Provides therapeutic technology in combination with medication | Corporate Officer/Principal | - |
Formation de Alex Mogle
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
The Hebrew University of Jerusalem
The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharma Two B Ltd.
Pharma Two B Ltd. Pharmaceuticals: MajorHealth Technology Manufactures combination drugs for neurological disorders | Health Technology |
Mapi-Pharma Ltd.
Mapi-Pharma Ltd. Pharmaceuticals: MajorHealth Technology Engages in the development of generic drugs that include complex active pharmaceutical ingredients, formulations and life cycle management products | Health Technology |
Stem Cell Medicine Ltd.
Stem Cell Medicine Ltd. Pharmaceuticals: OtherHealth Technology Provides therapeutic technology in combination with medication | Health Technology |
















